Melanoma trials in Germany
11 of 48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleHigh-precision Radiosurgery Followed by Minimally Invasive Surgical Approach in Patients With High-prominence Uveal Melanoma: Modern Radiation Techniques and Outcomes
- Where
- Essen
- Age
- 18 years and over
- People
- 250
- Run by
- University Hospital, Essen
See details and how to joinNCT07913412 - No phaseTaking peopleDevelopment and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
- Where
- Tübingen
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Mitra Bio
See details and how to joinNCT07883954 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 3Enrolling by invitationA Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
- Where
- Berlin, Essen, Hamburg, Munich
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00 - Phase 4Taking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Heidelberg, Munich
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseNot yet taking people in GermanyNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Heidelberg
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759 - No phaseTaking peopleVideo-Tumorboard PLUS
- Where
- Bonn, Dresden, Münster
- Age
- 18 years and over
- People
- 300
- Run by
- University Hospital Muenster
See details and how to joinNCT06980740 - No phaseTaking peopleObservational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.
- Where
- Heidelberg, München, Tübingen
- Age
- 18 years and over
- People
- 196
- Run by
- Pamgene International B.V.
See details and how to joinNCT06784778 - No phaseTaking peopleThe Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
- Where
- Dresden
- Age
- 18 years and over
- People
- 3,000
- Run by
- Technische Universität Dresden
See details and how to joinNCT06765850 - No phaseTaking peopleArtificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
- Where
- Tübingen
- People
- 3,000 worldwide
- Run by
- German Cancer Research Center
See details and how to joinNCT06621810 - No phaseTaking peopleBinimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
- Where
- Ahaus, Aschaffenburg, Augsburg, Berlin, Bremerhaven, Buxtehude, Chemnitz, Donauwörth, Dresden, Duisburg, Erfurt, Essen, Gera, Giessen, Goslar, Göttingen, Hamburg, Hanover, Heidelberg, Karlsruhe, Kiel, Landshut, Leipzig, Lübeck, Ludwigshafen, Magdeburg, Mainz, Mannheim, Marburg, Minden, München, Münster, Nuremberg, Regensburg, Schorndorf, Schwerin, Stolberg, Trier, Tübingen, Zwickau
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- Pierre Fabre Pharma GmbH
See details and how to joinNCT04045691